| Price | 934.00p on 03-04-2026 at 04:45:12 |
|---|---|
| Change | 0.00p 0% |
| Buy | 942.00p |
| Sell | 934.00p |
| Last Trade: | Buy 17.00 at 934.00p |
| Day's Volume: | 0 |
| Last Close: | 934.00p |
| Open: | 0.00p |
| ISIN: | GB0004559349 |
| Day's Range | 0.00p - 0.00p |
| 52wk Range: | 480.00p - 1,000.00p |
| Market Capitalisation: | £297.97m |
| VWAP: | 0.00p |
| Shares in Issue: | 31.90m |
Sector: Closed End Investments
Listed In: FTSE All-Share, FTSE Small Cap
Int.biotech. (IBT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 17 | 934.00p | Suspected BUY Trade |
16:35:07 - 02-Apr-26 |
| Buy* | 1,277 | 939.432p | Ordinary |
16:29:56 - 02-Apr-26 |
| Buy* | 59 | 942.00p | Automatic Execution |
16:24:05 - 02-Apr-26 |
| Buy* | 319 | 940.08p | Ordinary |
16:19:33 - 02-Apr-26 |
| Buy* | 1,592 | 940.077p | Ordinary |
16:08:11 - 02-Apr-26 |
| Buy* | 70 | 942.00p | Automatic Execution |
16:07:02 - 02-Apr-26 |
| Sell* | 41 | 936.00p | Automatic Execution |
16:02:26 - 02-Apr-26 |
| Buy* | 209 | 944.154p | Ordinary |
15:48:06 - 02-Apr-26 |
| Buy* | 209 | 944.148p | Ordinary |
15:38:45 - 02-Apr-26 |
| Buy* | 485 | 942.00p | Automatic Execution |
15:35:58 - 02-Apr-26 |
Int.biotech. (IBT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 1st Apr 2026 5:24 pm | RNS | Transaction in Own Shares |
| 1st Apr 2026 12:02 pm | RNS | Net Asset Value(s) |
| 31st Mar 2026 2:55 pm | RNS-R | IBT portfolio company Apellis acquired by Biogen |
| 31st Mar 2026 12:00 pm | RNS | Net Asset Value(s) |
| 30th Mar 2026 11:46 am | RNS | Net Asset Value(s) |
| 27th Mar 2026 11:51 am | RNS | Net Asset Value(s) |
| 26th Mar 2026 11:56 am | RNS | Net Asset Value(s) |
| 25th Mar 2026 2:43 pm | RNS-R | IBT portfolio company Terns acquired by Merck |
| 25th Mar 2026 12:01 pm | RNS | Net Asset Value(s) |
| 24th Mar 2026 11:54 am | RNS | Net Asset Value(s) |
